REMEGEN LTD has a total of 59 patent applications. Its first patent ever was published in 2012. It filed its patents most often in China, EPO (European Patent Office) and Taiwan. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are ALLYSTA PHARMACEUTICALS INC, AYALA PHARMACEUTICALS INC and BIOSTAPRO AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 10 | |
#2 | EPO (European Patent Office) | 7 | |
#3 | Taiwan | 7 | |
#4 | WIPO (World Intellectual Property Organization) | 7 | |
#5 | Republic of Korea | 6 | |
#6 | United States | 5 | |
#7 | Australia | 4 | |
#8 | Brazil | 4 | |
#9 | Canada | 4 | |
#10 | Singapore | 3 | |
#11 | Japan | 1 | |
#12 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Measurement | |
#5 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Heterocyclic compounds | |
#6 | Climate change adaptation technologies | |
#7 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Fang Jianmin | 50 |
#2 | Huang Changjiang | 32 |
#3 | Jiang Jing | 26 |
#4 | Ye Hui | 21 |
#5 | Yao Xuejing | 20 |
#6 | Xu Qiaoyu | 18 |
#7 | Luo Wenting | 12 |
#8 | Li Shenjun | 12 |
#9 | Wang Mingxue | 9 |
#10 | Li Hongwen | 9 |
Publication | Filing date | Title |
---|---|---|
CN110845480A | Difunctional cytotoxin and application thereof | |
US2020289663A1 | Use of anti-her2 antibody-drug conjugate in treating urothelial carcinoma | |
US2021087253A1 | Application of taci-fc fusion protein in preparation of drugs for treating neuromyelitis optica spectrum disorders and multiple sclerosis | |
CN109914987A | A kind of transmitting window assembly | |
CN110507824A | A kind of Anti-mesothelin antibodies and its antibody drug conjugate | |
US2016347817A1 | FGFR-FC fusion proteins and the use thereof | |
WO2016191765A1 | Fgfr-fc fusion proteins and the use thereof | |
EP3072907A1 | Anti-her2 antibody and conjugate thereof |